Showing results (301-310 of 349) with videos related to

Sort By:
Pageof 35
MMWR. Morbidity and Mortality Weekly Report|January 27, 2022
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021Tomás M León, Vajeera Dorabawila, Lauren Nelson, et al.
Emerging Infectious Diseases|February 26, 2014
Hantavirus infections among overnight visitors to Yosemite National Park, California, USA, 2012Jonathan J Núñez, Curtis L Fritz, Barbara Knust, et al.
Health Affairs (Project Hope)|May 12, 2021
Racial/Ethnic Disparities In COVID-19 Exposure Risk, Testing, And Cases At The Subcounty Level In CaliforniaMarissa B Reitsma, Anneke L Claypool, Jason Vargo, et al.
Journal of the American Chemical Society|May 8, 2024
Identification, Characterization, and Electronic Structures of Interconvertible Cobalt-Oxygen TAML IntermediatesDeesha D Malik, Wooyeol Ryu, Yujeong Kim, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 19, 2002
Identification of metabolites of a substance P (neurokinin 1 receptor) antagonist in rat hepatocytes and rat plasmaCornelis E C A Hop, Yanfeng Wang, Sanjeev Kumar, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 14, 1997
Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptorS Patel, S Freedman, K L Chapman, et al.
Radiation Research|August 17, 2023
Trends in Radiation Dose to the Contralateral Breast During Breast Cancer Radiation TherapyGordon P Watt, Susan A Smith, Rebecca M Howell, et al.
JACC. Cardiooncology|October 4, 2021
Coronary Artery Disease in Young Women After Radiation Therapy for Breast Cancer: The WECARE StudyLauren E Carlson, Gordon P Watt, Emily S Tonorezos, et al.
JAMA Network Open|September 28, 2019
Association of a Pathway-Specific Genetic Risk Score With Risk of Radiation-Associated Contralateral Breast CancerGordon P Watt, Anne S Reiner, Susan A Smith, et al.
Pageof 35